The investment marks the largest single life science investment in North Carolina history. It tops the $1.8 billion investment announcement in 2016 from Novo Nordisk for one of its facilities in ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...

announcing plans to build a $4.1 billion fill-and-finish facility for injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk’s ...

Novo Nordisk is not concerned by the ongoing US trade war and the 25% tariff set to go into effect for pharmaceutical ...

While attention has been on Apple’s progress (or lack thereof) in Research Triangle Park, the company continues to spend on a ...

Novo Nordisk's semaglutide ... One of these, at Clayton in North Carolina, will focus on producing active pharmaceutical ingredients (APIs) for isemaglutide and other diabetes drugs, while ...

Novo Nordisk (NVO), the maker of the popular diabetes and weight-loss drugs Ozempic and Wegovy, expects at least some ...

The CEO of Novo Nordisk warned of the impact of tariffs on the pharmaceutical industry. Weight-loss drugs, including Ozempic ...

The entrance to one of Novo Nordisk’s two manufacturing facilities in Clayton, North Carolina on June 24, 2024. Brian Gordon [email protected] ...

Novo Nordisk (NVO) is not concerned by the ongoing ... Lilly recently built out a new manufacturing site in North Carolina, dedicated to producing GLP-1 injectable pens. Novo is also already ...